Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-040174
Filing Date
2020-08-14
Accepted
2020-08-14 07:30:37
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-10q_20200630.htm 10-Q 1535913
2 EX-4.1 vcnx-ex41_475.htm EX-4.1 292680
3 EX-10.5 vcnx-ex105_477.htm EX-10.5 158342
4 EX-10.6 vcnx-ex106_476.htm EX-10.6 278928
5 EX-31.1 vcnx-ex311_249.htm EX-31.1 22237
6 EX-31.2 vcnx-ex312_248.htm EX-31.2 22423
7 EX-32.1 vcnx-ex321_247.htm EX-32.1 10938
  Complete submission text file 0001564590-20-040174.txt   5926970

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vcnx-20200630.xml EX-101.INS 910877
9 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20200630.xsd EX-101.SCH 46487
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vcnx-20200630_cal.xml EX-101.CAL 30984
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcnx-20200630_def.xml EX-101.DEF 156340
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20200630_lab.xml EX-101.LAB 345833
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20200630_pre.xml EX-101.PRE 281658
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 201101360
SIC: 2834 Pharmaceutical Preparations